Poster Abstract Session:
50. HAI: Device Associated Infections
Thursday, October 8, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID

Presentations:
267
Trends in the distribution and antimicrobial susceptibility of causative pathogens of device associated infection in Korean intensive care units from 2006 to 2013: results from the Korean Nosocomial Infections Surveillance (KONIS) system
Jun Yong Choi, MD, PhD ; Yee Gyung Kwak, MD ; Hyeonmi Yoo, RN ; Sang-Oh Lee, MD ; Hong Bin Kim, MD, PhD ; Su Ha Han, RN ; Hee Jung Choi, MD ; Hyo Youl Kim, MD, PhD ; Sung Ran Kim, RN ; Tae Hyong Kim, MD, PhD ; Hyukmin Lee, MD, PhD ; Hee Kyung Chun, RN ; Jae-Seok Kim, MD, PhD ; Byung Wook Eun, MD, PhD ; Hyun-Sook Koo, RN ; Eun-Hee Cho, MD ; Kyungwon Lee, MD, PhD
Posters
  • ID week poster.pdf (490.1 kB)
  • 268
    Effects of Overnight Attending Intensivist Coverage in Medical Intensive Care Units on Infection-Related Indicators
    Kathleen Mcmullen, MPH, CIC ; Abhaya Trivedi, MD ; Hilary M. Babcock, MD, MPH ; Marin H. Kollef, MD
    Posters
  • MICU Nightime Intensivist.pdf (521.2 kB)
  • 269
    Incidence and Characteristics of Ventilator-Associated Events Reported from Long Term Care Hospitals to the National Healthcare Safety Network, 2013-2014
    Shelley S. Magill, MD, PhD ; Qunna Li, MSPH, MMs, MBBS ; Cindy Gross, MT, SM (ASCP), CIC ; Jonathan R. Edwards, MStat
    270
    From the Central Line to the Ventilator: Do Resident Physicians Know and Practice Mitigating Risk?
    Mohamad G. Fakih, MD, MPH, FIDSA, FSHEA ; Ana C. Bardossy, MD ; Takiah Williams, BSN, RN ; Raymond Hilu, MD ; Katherine Reyes, MD, MPH ; Marcus Zervos, MD, FIDSA ; Debi Hopfner, RN, BSN ; Mina El-Kateb, MD ; Elango Edhayan, MD ; Susan Szpunar, PhD ; Steven Minnick, MD, MBA ; Louis Saravolatz, MD, FIDSA
    272
    Impact of an Eight Year Program to Reduce Central Line Associated Blood Stream Infection (CLABSI) in a University Teaching Hospital
    France Paquet, RN, M.Sc., VA-BC(TM), CVAA(C) ; Charles Frenette, MD, FSHEA ; Connie Patterson, RN, BSN, ; Anique Decary, RN, BN, CIC
    273
    Prevention of CLABSIs: More than an Inpatient Problem
    Jessica Howard-Anderson, MD ; Jonathan Grein, MD ; Rekha Murthy, MD, FIDSA, FSHEA ; Zachary Rubin, MD
    Posters
  • IDweek poster.JHA.pdf (508.4 kB)
  • 274
    Using DMAIC as a Road Map to Approach Zero Central Line Infections (CLABSIs)
    Lori Finkelstein-Blond, RN, MA, CIC ; Samantha Meyerholz, BS, MS Eng ; Stephen Ceresoli, BS, MS Eng ; Roopa Kohli-Seth, MD ; Fran Wallach, MD
    Posters
  • Poster IDWeek.pdf (167.1 kB)
  • 276
    What Happens to a Discharged Peripherally Inserted Central Catheter?
    Aneta Tarasiuk-Rusek, MD ; Maryrose Laguio-Vila, MD
    Posters
  • IDSA poster PICC lines.pdf (466.7 kB)
  • 277
    Incidence and risk factors for peripherally inserted central catheter-associated infections in inpatient and outpatient settings
    Rachel Blair, MPH ; Jennifer Brite, MPH ; Natalie Bell, RN, MSN, ACNP-BC, OCN ; Janet Eagan, RN, MPH, CIC ; Mini Kamboj, MD
    Posters
  • ID Week Poster5.pdf (163.9 kB)
  • 278
    A multicenter pragmatic interrupted time series analysis of chlorhexidine bathing in community hospital intensive care units
    Kristen Dicks, MD, MPH ; Eric Lofgren, MSPH, PhD ; Rebekah W. Moehring, MD, MPH ; Michael J. Durkin, MD, MPH ; Arthur W. Baker, MD, MPH ; Luke F. Chen, MBBS, MPH, CIC, FRACP ; Daniel J. Sexton, MD, FIDSA, FSHEA ; Sarah S. Lewis, MD MPH ; Deverick Anderson, MD, MPH, FIDSA, FSHEA
    280
    Performance of the SteriPath Device in Removing Skin Contamination from Blood Culture Samples
    Parul Patel, BS MT(ASCP), CCRP ; Donna Schora, MT(ASCP) ; Richard Thomson Jr., PhD ; Lance Peterson, MD, FIDSA, FSHEA
    Posters
  • IDSA 2015 SPD poster final.pdf (716.2 kB)
  • 282
    Development of Antimicrobial Gendine Coated Central Catheters: In Vivo Biocompatibility and In Vitro Efficacy
    Mohamed Jamal, PhD ; Ray Hachem, MD, FIDSA ; Joel Rosenblatt, PhD ; Mark Mcarthur, DVM ; Edd Felix, BS ; Ying Jiang, MS ; Ramesh Tailor, Ph.D. ; Issam Raad, MD, FACP, FIDSA, FSHEA
    284
    Short Dwell Time Ethanol Lock Therapy for Central Line-associated Bloodstream Infection in Children
    Tomohiro Katsuta, MD, PhD ; Rei Fumimoto, MD ; Takumi Moriuchi, MD ; Ayano Shinagawa, MD ; Ryo Niiya, MD ; Yusuke Miyaji, MD, PhD ; Yukitsugu Nakamura, MD, PhD
    285
    Successful Salvage of vascular access in Central Line Associated Bloodstream Infections (CLABSI) Using Catheter Lock Consisting of Minocycline, EDTA and 25% Ethanol (M-EDTA-ETOH)
    Issam Raad, MD, FACP, FIDSA, FSHEA ; Anne Marie Chaftari, MD ; Ramia Zakhour, MD ; Ammar Yousif, MD ; Ying Jiang, MS ; Mary Jordan, M.D ; Zainab Al Hamal, MD ; George M. Viola, MD, MPH ; Michael Fisch, MD ; Ray Hachem, MD, FIDSA
    Posters
  • CVC Lock.pdf (652.4 kB)
  • 287
    Using the Comprehensive Unit-based Safety Program (CUSP) Model for Sustained Reduction in Hospital Infections
    Kristen Miller, DrPh, MSPH ; Lorraine Adkins, BSN, RN, CIC ; Michael Benninghoff, DO ; Carol Briody, MT (ASCP), CIC ; Donna Casey, BSN, MA, RN, FABC, NE-BC ; Nancy Davis, BSN, RN, CIC ; Robert Dressler, MD, MBA ; Jill K. Kane, BSN, RN, CCRN ; Amy Llewellyn, BSN, RN, CCRN ; Vinay Maheshwari, MD ; Dannette Mitchell, MSN, APRN, ACNS-BC, CCRN ; Badrish Patel, MD ; Carol Ritter, MSN, RN, CCRN, CNML ; Maureen Seckel, APN, MSN, ACNS-BC, CCNS, FCCM ; Sandy Wakai, MSN, RN, CCRN ; Kathleen Wroten, MSN, RN, CIC ; Marci Drees, MD, MS
    288
    Reduction in CAUTI and†Urinary Catheter Utilization Rates on†a Medical Unit and a Respiratory Step Down Unit
    Marie Moss, RN, BSN, MPH, CIC ; Brian Koll, MD, FACP, FIDSA ; Aileen Tanafranca, MSN, RN, CCRN, NE-BC ; Barbara Barnett, MD ; Margaret Amato-Hayes, MSN, RN, NE-BC ; Leslyn Williamson, MPH, MSN, DNP, RN, NEA-BC ; Samuel Acquah, MD ; Robbie Freeman, MSN, RN-BC ; Irene Jankowski, MSN, APN-BC, CWOCN ; Jason Filopei, MD ; Ryu Tofts, MD
    Posters
  • MossIDwk2015 (2)final.pdf (1.4 MB)
  • 290
    Hospital-wide Point Prevalence Survey of Inappropriate Use of Urinary Catheterization: Indications and Consequences
    Pasri Maharom, MD, MPH ; Apanaree Bhekasuta, MD ; Aungsumalin Sricharoon, BNS ; Duangkamol Chatngern, BNS, MS ; Kaimuk Thongyen, BNS ; Chirapan Tantimongkolsuk, MD
    Posters
  • IDWeek 2015_poster.pdf (266.2 kB)
  • 291
    How Good Are Medical and Surgical Residents at Addressing Urinary Catheter Risk? A Survey of 2 Large Teaching Hospitals
    Mohamad G. Fakih, MD, MPH, FIDSA, FSHEA ; Ana C. Bardossy, MD ; Takiah Williams, BSN, RN ; Katherine Reyes, MD, MPH ; Marcus Zervos, MD, FIDSA ; Steven Minnick, MD, MBA ; Raymond Hilu, MD ; Elango Edhayan, MD ; Mina El-Kateb, MD ; Susan Szpunar, PhD ; Karen Jones, RN, BSN ; Louis Saravolatz, MD, FIDSA
    292
    Changing the Culture of Culturing: A Multifaceted Approach to Reduction of Catheter-Associated Urinary Tract Infections in the ICU with an Emphasis on Appropriate Indications for Obtaining a Urine Culture
    Katherine Mullin, MD ; Christopher Kovacs Jr., MD ; Cynthia Fatica, RN, BSN, CIC ; Colette Einloth, BA ; Elizabeth Neuner, PharmD ; Edward Manno, MD ; Jorge Guzman, MD ; Eric Kaiser, MD ; Venugopal Menon, MD ; Marc Popovich, MD ; Leticia Castillo, MD ; Thomas G. Fraser, MD, FSHEA
    Posters
  • CAUTI.png (103.6 kB)
  • 293
    Catheter Associated Urinary Tract Infections (CAUTI) in Bladder Cancer Patients Post Cystectomy with a Neobladder
    Mina Gafary, BS ; Natalie Bell, RN, MSN, ACNP-BC, OCN ; Janet Eagan, RN, MPH, CIC ; Mini Kamboj, MD
    Posters
  • Neobladder Poster-Final.pdf (602.6 kB)
  • 294
    Improving the Culture of Culturing: When Do Resident Physicians Obtain Urine Cultures, and What Do they Do with Them?
    Mohamad G. Fakih, MD, MPH, FIDSA, FSHEA ; Karen Jones, RN, BSN ; Elango Edhayan, MD ; Ana C. Bardossy, MD ; Takiah Williams, BSN, RN ; Katherine Reyes, MD, MPH ; Raymond Hilu, MD ; Marcus Zervos, MD, FIDSA ; Mina El-Kateb, MD ; Rebecca Battjes, BA ; Steven Minnick, MD, MBA ; Louis Saravolatz, MD, FIDSA
    295
    Effectiveness of a Daily Verbal Reminder to Decrease the Duration of Indwelling Urinary Catheter Use
    Logan Felix, MD ; Barbara Smith, RN, BSN, MPA, CIC ; Eloisa Santos, RN, BSN, MA, MEd, CIC ; Angela Gabasan, RN, BSN, MSN, CIC ; Olena Dzenkevych, MS ; Ismini Kourouni, MD ; Robert Klein, MD, FIDSA
    Posters
  • CAUTI QI Poster Final.png (578.5 kB)
  • 296
    The Power of a System: Addressing Catheter-Associated Urinary Tract Infections (CAUTI) in Intensive Care units
    Mohamad G. Fakih, MD, MPH, FIDSA, FSHEA ; Michelle Heavens, BSN, MHA ; Julie Grotemeyer, BS ; Ann Hendrich, RN, PhD
    Posters
  • CAUTI Poster-final.pdf (230.6 kB)
  • 297
    Klebsiella pneumoniae Catheter-Associated Urinary Tract Infections are Associated with Acute Changes in Mental Status
    Chelsie Armbruster, PhD ; Katherine Prenovost, PhD ; Harry Mobley, PhD ; Lona Mody, MD, MSc
    Posters
  • Poster_297.jpg (345.4 kB)
  • 298
    Catheter-associated Urinary Tract Infections Attributed to Yeast Reported to the Centers for Disease Control and Preventionís National Healthcare Safety Network, 2014
    Meghan Lyman, MD ; Alison S. Laufer-Halpin, Ph.D. ; Lindsey M. Weiner, MPH ; Jonathan R. Edwards, MStat ; Kelly Peterson, BBA ; Margaret Dudeck, MPH, CPH ; Katherine Allen-Bridson, RN, BSN, MScPH, CIC ; Carolyn Gould, MD, MSCR
    Posters
  • Lyman--Final CAUTI Poster.pdf (207.6 kB)
  • 299
    Emergency Department Catheter-associated Urinary Tract Infection Prevention: Role of the Clinical Nurse
    Eileen J. Carter, PhD, RN ; Corine Sinnette, MA, MPH ; Leslie Mandel, PhD, MA, MS ; Jeremiah Schuur, MD, MHS
    Posters
  • IDWEEK2015_RN_CAUTI_10_1_15.pdf (573.7 kB)
  • 300
    Use of Antibacterial Envelope to Reduce Cardiac Implantable Electronic Device (CIED) Infections
    Amir Azarbal, MD ; Mohammed Raja, M.D ; Morgan Scully, MD ; Ali Hassoun, MD FIDSA FACP
    301
    Cardiac Implantable Electronic Device Infection due to Propionibacterium Species
    Abdelghani El Rafei, MD ; Daniel Desimone, MD ; Muhammad R. Sohail, MD, FIDSA ; James Steckelberg, MD, FIDSA ; Walter R. Wilson, MD, FIDSA ; Larry Baddour, MD, FIDSA
    302
    Current management of cardiac implantable electronic device infections: results of an Emerging Infections Network survey
    Stephen Liang, MD ; Susan E. Beekmann, RN, MPH ; Philip M. Polgreen, MD ; David K. Warren, MD, MPH, FIDSA, FSHEA
    303
    Prolonged Antibiotic Prophylaxis after Left Ventricular-Assist Device (LVAD) Implantation is Associated with Increased Antibacterial Resistance
    Dimitrios Farmakiotis, MD ; Alyssa R. Letourneau, MD, MPH ; Alicia Galar, PharmD, PhD ; Sophia Koo, MD ; James Maguire, MD ; Michael M. Givertz, MD ; Lindsey R. Baden, MD
    Posters
  • LVAD poster.pdf (1.6 MB)
  • 304
    Antimicrobial Efficacy of Chlorhexidine-Minocycline/Rifampin (CHX-M/R) Coated Nephrostomy Catheter against Multi-drug Resistant Pathogens including Carbapenem-Resistant Enterobacteriaceae
    Mohamed Jamal, PhD ; Joel Rosenblatt, PhD ; Anne Marie Chaftari, MD ; Ying Jiang, MS ; Ray Hachem, MD, FIDSA ; Issam Raad, MD, FACP, FIDSA, FSHEA
    305
    Development and Efficacy of Chlorhexidine (CHX)-Minocycline/Rifampin (MR) Impregnated Penile Implants Against Resistance Pathogenes
    Mohamed Jamal, PhD ; Joel Rosenblatt, PhD ; Anne-Marie Chaftari, MD ; Ying Jiang, MS ; Ray Hachem, MD, FIDSA ; Issam Raad, MD, FACP, FIDSA, FSHEA
    Posters
  • Penile.pdf (706.5 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.